Ellen R. Strahlman

Age : 64

Public asset : 655,849 USD

Linked companies :

Altria Group, Inc. -

Eyenovia, Inc.

Summary

Ellen R. Strahlman is on the board of Altria Group, Inc., Losonoco Ltd. and Eyenovia, Inc.

She previously occupied the position of Chief Medical Officer, EVP-Research & Development at Becton, Dickinson & Co., Chief Medical Officer & Senior Vice President at GSK Plc, Principal at Merck & Co., Inc., Vice President-Worldwide Business Development at Pfizer Inc., Chief Medical Officer & Global Head-Research at Bausch & Lomb, Inc. and Principal at Novartis Corp.

Dr. Strahlman received an undergraduate degree from Harvard University, a doctorate from The Johns Hopkins University School of Medicine and a graduate degree from Johns Hopkins Bloomberg School of Public Health.

Current positions of Ellen R. Strahlman

Name	Title	Since
Altria Group, Inc. (Tobacco)	Independent Director	2020
Eyenovia, Inc. (Pharmaceuticals)	Independent Director	2022
Losonoco Ltd.	Director	2009

Holdings of Ellen R. Strahlman

Name	Equities	%	Valuation
Altria Group, Inc. (MO) (Tobacco)	13,896	0.0008%	558,202 USD
Eyenovia, Inc. (EYEN) (Pharmaceuticals)	75,113	0.18%	97,647 USD

Ellen R. Strahlman: Personal Network

Name	Linked companies
Murray R. Garnick	Altria Group, Inc.
Heather Newman	Altria Group, Inc.
Salvatore Mancuso	Altria Group, Inc.
Steven D’Ambrosia	Altria Group, Inc.
Jody Begley	Altria Group, Inc.
Mario Max Yzaguirre	Altria Group, Inc.
Lee Kramm	Eyenovia, Inc.
George Muñoz	Altria Group, Inc.
Marjorie M. Connelly	Altria Group, Inc.
Daniel J. Bryant	Altria Group, Inc.